title: An innovative approach to determine fetal risk: the FDA Office of Women's Health pregnancy exposure registry web listing.
authors.affiliation: Food and Drug Administration, Office of Women's Health, Rockville, Maryland, USA. pellavi.sharma@fda.hhs.gov
authors.forename: Pellavi
authors.initials: P
authors.lastname: Sharma
authors.forename: Ameeta
authors.initials: A
authors.lastname: Parekh
authors.forename: Kathleen
authors.initials: K
authors.lastname: Uhl
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000328:Adult; D005260:Female; D006291:Health Policy; D006801:Humans; D020407:Internet / Q000331:legislation & jurisprudence*; D018811:Maternal Exposure / Q000517:prevention & control; D011247:Pregnancy; D011295:Prenatal Care / Q000331:legislation & jurisprudence; D011296:Prenatal Diagnosis / Q000379:methods*; D011297:Prenatal Exposure Delayed Effects / Q000517:prevention & control*; D012042:Registries; D014481:United States; D014486:United States Food and Drug Administration